SCHEMBL547121

SCHEMBL547121

CCN[C@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.61
NAALAD2 Q9Y3Q0 1/20 0.57
MME P08473 6/20 0.56
ACE P12821 6/20 0.56
CPA1 P15085 1/20 0.56
ACE2 Q9BYF1 1/20 0.56
SLC7A5 Q01650 1/20 0.51
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1287829 1.00 FOLH1 (0.61) FOLH1NAALAD2MMEACECPA1
SCHEMBL547122 1.00 FOLH1 (0.61) FOLH1NAALAD2MMEACECPA1
Hydrochloric Acid SCHEMBL28885042 0.98 FOLH1 (0.60) FOLH1NAALAD2MMEACECPA1
Hydrochloric Acid SCHEMBL7310747 0.98 FOLH1 (0.60) FOLH1NAALAD2MMEACECPA1
Hydrochloric Acid SCHEMBL7310754 0.98 FOLH1 (0.60) FOLH1NAALAD2MMEACECPA1
SCHEMBL6443921 0.87 FOLH1 (0.55) FOLH1NAALAD2MMEACECPA1
SCHEMBL6443925 0.87 FOLH1 (0.55) FOLH1NAALAD2MMEACECPA1
SCHEMBL25764848 0.86 TDP1 (0.52) FOLH1NAALAD2MMEACECPA1
SCHEMBL25764849 0.86 TDP1 (0.52) FOLH1NAALAD2MMEACECPA1
SCHEMBL15095619 0.86 ESR1 (0.53) FOLH1NAALAD2MMEACECPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2508611-B1 Process for production of triprenyl phenol compounds TMS CO LTD (JP) 2019-05-08 EP claimed
EP-2508611-B1 Process for production of triprenyl phenol compounds TMS CO LTD (JP) 2019-05-08 EP disclosed
EP-2604697-B1 Triprenyl phenol compounds, process for their production and use as thrombolysis enhancer UNIV TOKYO AGRICULTURE & TECHNOLOGY TLO CO LTD (JP) 2015-07-01 EP disclosed
US-8883462-B2 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY TLO CO., LTD. (JP) 2014-11-11 US disclosed
EP-2000540-B1 TRIPRENYL PHENOL COMPOUND, PROCESS FOR PRODUCTION OF TRIPRENYL PHENOL COMPOUND, AND THROMBOLYSIS ENHANCER UNIV TOKYO AGRICULTURE & TECHNOLOGY TLO CO LTD (JP) 2014-05-14 EP disclosed
EP-2604697-A1 Triprenyl phenol compounds, process for their production and use as thrombolysis enhancer Tokyo University of Agriculture and Technology TLO (JP) 2013-06-19 EP disclosed
EP-2508611-A1 Process for production of triprenyl phenol compounds Tokyo University of Agriculture and Technology TLO Co., Ltd. (JP) 2012-10-10 EP disclosed
US-20120100579-A1 TRIPRENYL PHENOL COMPOUND, PROCESS FOR PRODUCTION OF TRIPRENYL PHENOL COMPOUND, AND THROMBOLYSIS ENHANCER TOKYO UNIVERSITY OF AGRICLATURE AND TECHNOLOGY TLO CO., LTD. (JP) 2012-04-26 US disclosed
US-8110596-B2 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY TLO CO., LTD. (JP) 2012-02-07 US disclosed
US-20090216028-A1 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY TLO CO., LTD. (JP) 2009-08-27 US disclosed
EP-2000540-A9 TRIPRENYL PHENOL COMPOUND, PROCESS FOR PRODUCTION OF TRIPRENYL PHENOL COMPOUND, AND THROMBOLYSIS ENHANCER Tokyo University of Agriculture and Technology TLO Co., Ltd. (JP) 2009-03-25 EP disclosed
EP-2000540-A2 TRIPRENYL PHENOL COMPOUND, PROCESS FOR PRODUCTION OF TRIPRENYL PHENOL COMPOUND, AND THROMBOLYSIS ENHANCER Tokyo University of Agriculture and Technology TLO Co., Ltd. (JP) 2008-12-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090216028-A1 Triprenyl phenol compound, process for production of triprenyl phenol compound, and thrombolysis enhancer PLAT, F2R, F12 FOLH1 585/4885NAALAD2 1047/4885MME 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.